Clinical Trial Update: Polypharmacy in Clozapine-resistant Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating polypharmacy in clozapine-resistant schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

Sponsor: Niuvanniemi Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED